As we approach the end of British Heart Week, we reflect on some of the key stats around heart conditions in the UK and our contribution as a company to help bring cutting-edge treatments to patients with cardiovascular diseases
British Heart Week 2022
More Insights
Conceptual modelling and NICE requirements: a significant change or hill of beans?
Written by Alec Miners, Head of Health Economics The National Institute for Health and Care Excellence’s (NICE’s) new processes and methods guide includes several important changes to the way submitted economic evaluations should be conducted ... Read more
Patient Participation Groups: A voice for patients for 50 years
Written by Dom Partridge, Medical Writer 6th to 13th June 2022 is Patient Participation Group (PPG) Awareness Week; aiming to raise the profile of PPGs within primary healthcare. The first Patient Participation Group The first PPG was set up in ... Read more
The Innovative Medicines Fund is now available to fast-track non-cancer medicines recommended with managed access
The Innovative Medicines Fund (IMF) launched this month (June 2022) to support faster access to non-cancer drugs. This process involves NHS England and the National Institute for Health and Care Excellence (NICE) working in partnership with ... Read more
NICE tests a new approach for evaluating and reimbursing antimicrobials
Written by Chris Hellmund, Senior Medical Writer Antimicrobial resistance is a major threat to global health that threatens to reverse the progress of modern medicine. More infections are becoming harder to treat, and without coordinated efforts Read more